Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.
Current vascular pharmacology·2026
Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.
The American journal of surgical pathology·2026
TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026